A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
Grps 1, 2, 3 "This study will be testing the performance of ASV and DCV pediatric chewable
tablets.
Grp #4 The purpose of this group is to support the marketing authorization of a DCV 90-mg
tablet